Wealthsource Partners, LLC Cue Biopharma, Inc. Transaction History

Wealthsource Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 15, 2019	SELL	$6.78 - $9.28 $89,462 - $122,449	-13,195 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$7.18 - $9.65 $7,237 - $9,727	-1,008 Reduced 7.1%	13,195 $119,000
Q1 2019 May 16, 2019	SELL	$4.7 - $9.29 $26,827 - $53,027	-5,708 Reduced 28.67%	14,203 $110,000
Q4 2018 Feb 06, 2019	SELL	$4.35 - $8.73 $2,818 - $5,657	-648 Reduced 3.15%	19,911 $94,000
Q3 2018 Nov 13, 2018	SELL	$7.91 - $11.89 $1,613 - $2,425	-204 Reduced 0.98%	20,559 $186,000
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $226,939 - $300,648	20,763 New	20,763 $246,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthsource Partners, LLC with notifications on news.